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1. Introduction
Diabetes mellitus (DM) is one of the systemic diseases affecting a considerable number of
patients worldwide [1]. Numerous experimental and clinical studies on the complications of
DM have demonstrated extensive alterations in bone and mineral metabolism, linear
growth, and body composition [2]. Depletion of insulin in Type 1 Diabetes Mellitus (T1DM)
causes a reduction of bone mineral density and decreases skeletal mass, thus altering linear
growth, body composition and delaying fracture healing. A considerable sector of literature
was dedicated to studying the effects of T1DM on long bones; however, fewer studies dis‐
cussed the effects of T1DM type on the craniofacial complex which is regulated by hor‐
mones, nutrients, mechanical forces, and various local growth factors.
Bone metabolism in the craniofacial complex involves a mosaic growth sites that grow at
different rates and mature at different times, its growth and by analogy, the response to
growth disruption is much more complex than that of the appendicular skeleton. Previous
studies showed that T1DM may significantly affect the bone remodeling process which is
observed during conducting treatments involving the application of mechanical or function‐
al forces to the craniofacial complex and the teeth as those applied during orthodontic
movement. Moreover, it is expected that the T1DM may alter the general growth of patients
due to insulin deficiency and consequently leads to delayed skeletal maturation.
Type 1 diabetes mellitus (T1DM) is an endocrine–metabolic syndrome of childhood and
adolescence, characterized by hyperglycemia as a cardinal biochemical feature, with impor‐
tant consequences for physical and emotional development. Several mechanisms have been
reported to explain the altered bone remodeling in diabetes, one of which is diminished
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bone formation as a result of decreased osteoblastic activity or enhanced apoptosis of osteo‐
blastic cells. Another contributing factor may be increased bone resorptive activity. Howev‐
er, it is still controversial whether osteoclastic recruitment and function are altered in
diabetes, because no change or decrease in the activity of osteoclasts has been reported [1].
Among researchers, there is lack of consensus about the impact of this disease on dental
health. It has been suggested that hyperglycemia is associated with decreased salivary se‐
cretion and high salivary glucose levels, particularly in cases of severe insulin deficiency.
Consequently, an increased cariogenic challenge in such individuals can be expected. How‐
ever, no clear evidence has been found for an association between dental caries and diabe‐
tes mellitus [3].
The main aim of this chapter is to discuss the complexity of the dento-craniofacial system
and how it is affected by T1DM condition. Moreover, the various detrimental effects of
T1DM on the dento-craniofacial complex will be explored using the dynamic histomorpho‐
metric analysis and a histological study that will demonstrate that T1DM condition induced
various detrimental effects on the quality of bone and on the bone turnover process ob‐
served in the dento-craniofacial complex.
2. Effect of T1DM on Bone
2.1. Types of Bone formation in craniofacial complex
Bone forms in two ways, resulting in two types of mature bone – intramembranous and car‐
tilage. Cartilage bone forms in a replacement process within the cartilage models of the em‐
bryo and infant. Intramembranous bone forms through the activation of the osteoblast cell
or specialized bone forming cells in one of the layers of fetal connective tissue. The bones of
the cranial vault, the face, and the clavicle are intramembranous in origin. All other bones of
the body form from cartilage. Intramembranous bone include the mandible, the maxilla, the
premaxilla, the frontal bone, the palatine bone, the squamous part of temporal bone, the zy‐
gomatic bone, the medial plate of the pterygoid process, the vomer, the tympanic part of the
temporal bone, the nasal bone, the lacrimal bone, and the parietal bone. The original pattern
of intramembranous bone changes with progressive maturative growth when these bones
begin to adapt to environmental influences. This accounts for deformities due to malfunc‐
tion, disease and other environmental factors [4].
2.2. Causes of growth problems
Growth disturbances can be associated with specific anatomic or functional defects. They
may be of endocrine or non endocrine origin and may result from genetic, nutritional or en‐
vironmental factors. Disturbances in somatic growth show themselves in retardation or ac‐
celeration of the skeletal system, including the facial and cranial bones. Causes for growth
problems usually fall into the following categories [5]:
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• Familial short stature
Familial short stature is a tendency to follow the family's inherited short stature (shortness).
• Constitutional growth delay with delayed adolescence or delayed maturation
A child who tends to be shorter than average and who enters puberty later than average,
but is growing at a normal rate. Most of these children tend to eventually grow to approx‐
imately the same height as their parents.
• Illnesses that affect the whole body (Also called systemic diseases.)
Constant malnutrition, digestive tract diseases, kidney disease, heart disease, lung dis‐
ease, hepatic disease, diabetes, and severe stress can cause growth problems.
• Endocrine (hormone) diseases
Adequate production of the thyroid hormone is necessary for normal bone growth. Cush‐
ing's syndrome can be caused by a myriad of abnormalities that are the result of hyperse‐
cretion of corticosteroids by the adrenal gland. Growth hormone deficiency involves a
problem with the pituitary gland (small gland at the base of the brain) that secretes sever‐
al hormones, including growth hormone.
• Congenital (present at birth) problems in the tissues where growth occurs
A condition called intrauterine growth restriction (IUGR), slow growth within the uterus
occurs during a pregnancy. The baby is born smaller in weight and length than normal, in
proportion to his/her short stature.
2.3. Effect of DM on Bone and Growth
Hand-wrist radiographs have been studied in juvenile diabetics [6]. There is delayed ap‐
pearance or delayed development of a center of ossification, usually of a carpal bone. These
defects occur twice as frequently in boys than in girls, and the total incidence of juvenile dia‐
betics with anomalies and developmental defects is 24.3%. There is also retardation of bone
growth in 60% of diabetic males and 51% of diabetic females. The longer the duration of dia‐
betes, the greater the tendency to bone growth retardation. The decreased bone mass in dia‐
betics has been explained by decreased proliferative capacity of the diabetic fibroblasts, and
early senescence of all cells has been suggested as basic to the diabetic problem. This degen‐
eration would lead to early osteopenia in bone [6]. The yearly bone loss was reported to be
1.35% in patients with T1DM [7]. In addition, the rate of bone mineral loss is significantly
greater among patients with a deterioration of the metabolic state, despite increasing insulin
dosage, when compared with patients with unchanged or improved insulin secretion. This
may indicate that the exogenous insulin administration does not fully compensate for the
decrease in endogenous insulin secretion. These studies also showed increased bone resorp‐
tion in T1DM patients with no signs of vitamin D deficiency associated with the disease.
Vertebral bone density has been studied in T1DM children [7]. It was found that diabetic
children exhibited cortical bone density that was slightly, but significantly, lower than the
controls. The decrease in cortical bone density in the diabetic group did not correlate with
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age, sex, duration of diabetes, or glycosylated hemoglobin levels. These results suggested
that in children with uncomplicated T1DM, decreased vertebral bone density is a minor ab‐
normality that affects only cortical bone [6].
2.4. Outline of studying the effect of diabetes mellitus on craniofacial growth
Approximately 60% of adult bone mass including craniofacial bone is gained during the
peak of the growth period which coincides with the onset of T1DM condition affecting the
bone formation process [8]. It is worth mentioning here that although T1DM condition exact
etiological factors are totally unknown however; understanding the course of T1DM condi‐
tion and its impact on craniofacial development may lead to improving the oral health for a
large sector of the population worldwide.
Numerous experimental and clinical studies on the complications of DM have demonstrated
extensive alterations in bone and mineral metabolism, linear growth, and body composition.
Investigators in the fields of bone biology including orthodontics have long been interested
in the general causes that affect the normal growth of the craniofacial region. T1DM has
been shown to affect the general growth of patients with earlier onset of the disease, espe‐
cially onset before or around the circumpubertal growth spurts [9].
In general, growth of the craniofacial complex is controlled by genetic and environmental
factors [3, 10]. Regulatory mechanisms responsible for normal morphogenesis of the face and
head involve hormones, nutrients, mechanical forces, and various local growth factors. The
poor growth and alterations in bone metabolism have been associated with T1DM in both
humans and experimental animals [3]. It is of prime importance investigating the changes in
craniofacial bone structure and dynamic bone formation in DM condition to explore the impact
of the diabetic condition on various mandibular growth elements and bone quality.
The following parts of this chapter are going to focus on these points:
• Investigating the effects of juvenile diabetes on general craniofacial growth and skeletal
maturation.
• Analyzing the pattern of association between craniofacial morphology and skeletal matu‐
ration.
• Determination of the changes in bone morphology in diabetic rat mandible using micro-
C.T.
• Determination of the mineral apposition rate and the bone formation rate in diabetic rat
mandible using histomorphometric analysis.
2.5. Animal and Experimental diabetic Model
The animal studies using diabetic model presents various advantages when compared to
studies carried out on human diabetic cases. Human studies can be limited by small sample
sizes, cross-sectional designs, uncontrolled variables, and often retrospective nature, animal
models have been used to yield more rigorous analyses [11].
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2.6. Diabetic model
Experimental diabetic models include the streptozotocin-induced diabetic rat and the spon‐
taneously diabetic BioBreeding [12] rat. The occurrence of different abnormalities indicating
altered bone formation after inducing DM with streptozotocin (STZ) is well documented [3,
13, 14]. Streptozotocin-induced diabetes mellitus (STZ-DM), caused by the destruction of
pancreatic β-cells and is similar to T1DM in human, is characterized by mild to moderate
hyperglycemia, glucosuria, polyphagia, hypoinsulinemia, hyperlipidemia, and weight loss.
STZ-DM also exhibits many of the complications observed in human DM including en‐
hanced susceptibility to infection and cardiovascular disease, retinopathy, alterations in an‐
giogenesis, delayed wound healing, diminished growth factor expression, and reduced bone
formation [15].
2.7. Importance of testing the uncontrolled diabetic condition
In the usual clinical situation, although T1DM patient is treated with insulin, patient may
still suffer from an overall poor diabetic metabolic state with an uncontrollable blood glu‐
cose level and a high and sometimes changing insulin requirement [16].
2.8. Inducing diabetic condition
All the experimental protocols followed had been approved by the Institutional Animal
Care and Use Committee of Tokyo Medical and Dental University, and the experiments
were carried out under the control of the University’s Guidelines for Animal Experimenta‐
tion. In our investigation we explored the various effects of DM using the streptozotocin
DM model. Twelve 3-week old male Wistar rats were used for this study. They were ran‐
domly divided into two groups, the control group and the diabetes group (DM group), each
group consists of 6 rats. The rats in the control group were injected intra-peritoneal with a
single dose of 0.1M sodium citrate buffer (pH 4.5), while the rats in the DM group were in‐
jected intra-peritoneal with a single dose of citrate buffer containing 60mg/kg body weight
of streptozotocin (Sigma Chemical Co., St. Louis, MO, USA). [13, 16 - 18] All animals were
fed on standard Rodent diet (Rodent Diet CE-2; Japan Clea Inc., Shizuoka, Japan) with free
access to water. Body weights, the presence of glucose in urine and blood glucose levels
were recorded on day 0,2,7,14,21 and 28 after STZ injection.
Diabetes condition was determined by the presence of glucose in urine and blood. The urine
of the rats was tested using reagent strips (Uriace Ga; TERUMO). [20, 21] Blood samples of
the rats were obtained via vein puncture of a tail vein, and blood glucose levels were deter‐
mined using a glucometer (Ascensia Brio. Bayer Medical). Positive urine test and a blood
glucose level greater than 200 mg/dl was considered DM. [3]
Fig. 1. shows the weights of the rats (mean±SD) in both groups. DM group showed a signifi‐
cant decrease in weight. After STZ injection by 48 hours the urine test showed that the entire
DM group had a high glucose level and this was confirmed by the high blood glucose meas‐
urements as shown in Fig. 2. A Student’s t-test was used to compare the mean of weights
and blood glucose levels in both groups.
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Figure 1. Comparison between the changes of the rat’s weight in the control and DM group. * The weights of the DM
group are significantly decreased as compared to the weights of the control group (p<0.05).
Figure 2. Line graph represents the blood glucose levels for the control and DM group. The blood glucose level in DM
group increased significantly 48h post-STZ injection and during the entire experimental period. Values are mean±SD.
Significant differences between the two groups are marked with asterisks (p< 0.05).
 
2.9. Analytic studies conducted to test the effect of diabetic condition on craniofacial
growth
Cephalometric analysis
Cephalometric measurements are still one of the most widely spread diagnostic aids crucial
for the diagnosis of various abnormalities in the craniofacial complex [22].
Type 1 Diabetes406
The protocol for examining the cephalometric measurements in DM rats involves the fol‐
lowing steps:
• Prior to each radiographic session, the rats are anaesthetized with diethyl ether and intra‐
peritoneal injection of 8% chloral hydrate using 0.5ml/100g of body weight.
• Each animal is then placed in this specially-designed apparatus (Fig. 3) to maintain stand‐
ardized head posture and contact with the film (SGP-3, Mitsutoy, Tokyo, Japan) where
the head of each rat is fixed firmly with a pair of ear rods oriented vertically to the sagittal
plane and the incisors are fixed into a plastic ring.
• The settings of lateral and dorsoventral cephalometric radiographs are 50/55kVp,
15/10mA, and 20/60-sec impulses respectively.[11, 23]
• A 10 mm steel calibration rod is incorporated into the clear acrylic table on which the ani‐
mals are positioned for the radiographs.
• All the radiographs are developed and scanned at high resolution by the same operator.[11]
Figure 3. Apparatus for roentgenographic cephalometry
The cephalometric landmarks (Table 1; Fig. 4) were derived from previous studies on ro‐
dents.[11, 24-26] Selected linear measurements were then obtained (Table 2). To ensure relia‐
bility and replicability of each measurement, each distance was digitized twice and the two
values were averaged.
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Figure 4. Location of cephalometric points on radiographs: (A) Sagittal and (B) transverse.
Table 1. Definitions of radiographic points
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Table 2. Measurements of craniofacial skeleton
In our studies, evaluation of the craniofacial growth of diabetic rats at the age of 7 weeks
was done using lateral and dorsoventral cephalometric radiographs. All of the data in each
experiment were confirmed the normal distribution, so a Student’s t-test was used to com‐
pare the mean of each data recorded in the control group and in the DM group. All statisti‐
cal analyses were performed at a 5% significance level using statistic software (v. 10; SPSS,
Chicago, IL, USA).
2.9.1. Changes in the Total Skull
The size of total skull, denoted by Po-N, was significantly smaller in the DM group than in
the control group.
2.9.2. Changes in the Neurocranium
Cranial vault length (Po-E), total cranial base length (Ba-E), anterior cranial base length (So-
E), Occipital bone length (Ba-CB1), and posterior cranial base length (Ba-So) showed statisti‐
cally significant decrease in DM group (Table 3, Fig. 5, 6), while other dimensions exhibited
no significant differences.
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Table 3: Significant changes in the Total skull and Neurocranium
Po-N                  total skull length
Po-E cranial vault length
Ba-E total cranial base length
So-E anterior cranial base length  
Ba-CB1 occipital bone length
Ba-So posterior cranial base length
Table 3. Significant changes in the Total skull and Neurocranium
Figure 5. Neurocranium
Figure 6. Changes in the neurocranial measurements of the control and DM group. All the significant measurements
are shown in this figure. Values are mean±S.D. Significant differences between the two groups are marked with aster‐
isks (p<0.05).
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2.9.3. Changes in the Viscerocranium
All measurements of the viscerocranium, including the nasal length (E-N), palatal length
(Mu2-Iu), midface length (CB2-Iu), and viscerocranial height (E-Mu1) showed a statistically
significant decrease in DM group (Table 4, Fig. 7,8)
Table 4 : Significant changes in the Viscerocranium
E-N                Nasal length
Mu2-Iu Palate length
Cb2-Iu midface length
E-Mu1 Posterior viscerocranial height
Table 4. Significant changes in the Viscerocranium
Figure 7. Viscerocranium
Figure 8. Changes in the viscerocranial measurements of the control and DM group. All the viscerocranial measure‐
ments are significant. Values are mean±S.D. Significant differences between the two groups are marked with asterisks
(p<0.05).
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2.9.4. Changes in the Mandible
In the DM group, the posterior corpus length (Go-Mn), total mandibular length (Co-Il) and
the ramus height (Co-Gn) were significantly shorter than in the control group (Table 5, Fig.
9, 10), whereas no remarkable differences were found in the remaining dimensions.
Table 5: Significant changes in the Mandible
Go-Mn                 Posterior corpus length
Co-Il Total mandibular length
Co-Gn Ramus height
Table 5. Significant changes in the Mandible
Figure 9. Mandible
Figure 10. Changes in the mandible measurements of the control and DM group. Values are mean ± S.D.Significant
differences between the two groups are marked with asterisks (p<0.05).
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2.9.5. Changes in the Transverse X-ray
In transverse X-ray only the maximum cranial width (C1-C2) and the bizygomatic width
(Z1-Z2) were statistically decreased in DM group (Table 6, Fig. 11, 12).
All other linear measurements showed no significant differences between both groups
Table 6: Significant changes in the transverse X-ray
C1-C2             Maximum cranial width
Z1-Z2 Bizygomatic width
Table 6. Significant changes in the transverse X-ray
Figure 11. Transverse X-ray measurements
Figure 12. Changes in the transverse X-ray measurements of the control and DM group. Two measurements in the
transverse X-ray were significant. Values are mean±S.D. Significant differences between the two groups are marked
with asterisks (p<0.05)




2.10.1. Fluorescent dyes used for double labeling in histomorphometric analysis
Fluorochromes are calcium binding substances that are preferentially taken up at the site of
active mineralization of bone known as the calcification front, thus labeling sites of new
bone formation. They are detected using fluorescent microscopy on undecalcified sections.
Labeling bones with fluorochrome markers provides a means to study the dynamics of bone
formation. The rate and extent of bone deposition and resorption can be determined using
double and triple fluorochrome labeling sequences. The sequential use of fluorochromes of
clearly contrasting colors permits a more detailed record of events relating to calcification.
Flurochromes commonly used in mammals include tetracycline, calcein green, xylenol or‐
ange, alirazin red, and hematoporphyrin. Calcein is a fluoresces bright green when com‐
bined with calcium [27].
2.10.2. Calcein administrations and sections preparation
The steps needed for detecting the double labeling involves the following:
• Rats are subcutaneously injected with 50 mg/kg body weight calcein fluorescent marker
on day 21 and day 28 after STZ injection [28]. The time difference between the 2 injections
is one week to be able to compare the amount of bone formed during this period (Fig. 13).
• Sacrifice of all animals by transcardiac perfusion under deep anesthesia using 4% parafor‐
maldehyde in 0.1 M phosphate buffer (pH 7.4).
• Mandibles are dissected and fixed in the same solution for 24 hours.
• All specimens are embedded in polystyrene resin (Rigolac, Nisshin EM Co. Ltd., Tokyo,
Japan).
• Undemineralized ground frontal sections are processed to show the crown and both api‐
ces of buccal and lingual roots of the lower second molar [28].
Figure 13. Frontal sections of the mandibular second molar area. (A) Control; (B) DM. Fluorescent labeling on the peri‐
osteal surface indicates new bone formation.
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2.10.3. Method of analysis
The bone around the lower second molar is centrally located within the mandibular arch, and
because of the parallel alignment of the buccal and lingual roots this made a precise refer‐
ence when frontal sections are produced [29]. To conduct the histomorphometric analysis it
is essential to use a digitizing morphometry system to measure bone formation indices. The
system consists of a confocal laser scanning microscope (LSM510, Carl Zeiss Co. Ltd., Jena,
Germany), and a morphometry program (LSM Image Browser, Carl Zeiss Co. Ltd., Jena,
Germany).  Bone formation indices of the periosteal surfaces of the alveolar/jaw bone in‐
clude mineral apposition rate (μm/day) and bone formation rate (μm3/μm2/day), according to
the standard nomenclature described by [30]. The calcein-labeled surface (CLS, in mm) is
calculated as the sum of the length of double labels (Thomas et al.) plus one half of the length
of single labels (sL) along the entire endosteal or periosteal bone surfaces; that is, CLS ═ dL
+ 0.5sL [31]. The mineral apposition rate (MAR, in μ / day) is determined by dividing the mean
of the width of the double labels by the interlabel time (7 days). The bone formation rate (BFR)
is calculated by multiplying MAR by CLS [32]. Based on the reference line along the long axis
of the buccal root, the area superior to the root apex was considered alveolar bone, while the
area inferior to the root apex was considered the jaw bone. The lingual side of the bone is
excluded, because the existence of the incisor root may influence bone formation.
Figure 14. Schematic drawing of observation regions for dynamic bone histomorphometry. The periosteal surfaces
were delimited into 4 areas as alveolar crest (region 1), alveolar bone (region 2), buccal surface of the jaw bone (re‐
gion 3), and inferior border of the jaw bone (region 4).
The periosteal surfaces of the mandible are divided into four regions for analysis (Fig. 14.):
2.10.4. Histomorphometric indices
The obtained results in our study showed that in the alveolar bone (region 2), there was a
significant decrease in the MAR (Fig. 15A) BFR (Fig.15B) recorded in the DM group com‐
pared to the control group. However, in the alveolar crest (region 1), the MAR and the BFR in
the control and the DM groups were not significantly different. (P < 0.05). In the buccal surface
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(region 3) and inferior borders (region 4) of the jaw bone the MAR (Fig.15A) and BFR (Fig.
15B) were significantly suppressed compared with those in the control group (P < 0.05). Most
of the periosteal surfaces in the mandibular regions of the control group showed significant‐
ly higher values recorded for the mineral apposition rate and the bone formation rate when
compared to the DM group. These results agree with previous studies that recorded dimin‐
ished lamellar bone formation in DM rats’ femur and may suggest an association between the
DM condition and the decreased number and function of osteoblasts [16, 19]. The alveolar
crest region was the only region that did not show a significant difference in the mineral
apposition rate and the bone formation rate parameters among the two groups; this may be
attributed to the unique nature of this region exhibiting a highly intensive bone remodeling
process especially during the teeth eruption that decreases toward the base of the socket [33],
however further studies are needed to elaborate the detailed pattern of bone growth at the
alveolar crest region.
Figure 15. A) The changes in mineral apposition rate (MAR) of the mandible between the control group and the DM
group. Alveolar crest (region 1, upper 1/2 of the tooth root, near the tooth crown). Alveolar bone (region 2, lower 1/2
of the tooth root, near the root apex). Buccal surface of the jaw bone (region 3). Inferior border of the jaw bone (re‐
gion 4). The data are expressed as means ± SD. N = 5 for each group. *Significantly different from controls, with (p<0.05).
(B) The changes in the bone formation rate (BFR/BS) of the mandible between the control group and the DM group.
Alveolar crest (region 1, upper 1/2 of the tooth root, near the tooth crown). Alveolar bone (region 2, lower 1/2 of the
tooth root, near the root apex). Buccal surface of the jaw bone (region 3). Inferior border of the jaw bone (region 4). The
data are expressed as means ± S.D. N = 5 for each group. *Significantly different from controls, with (p<0.05).
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2.10.5. Microtomography of the mandible (Micro-CT)
Micro-computed tomography (micro-CT) has rapidly become a standard technique for the
visualization and quantification of the 3D structure of trabecular bone. Bone architecture
and mineralization are generally considered to be important components of bone quality,
and determine bone strength in conjunction with bone mineral density.
2.10.6. Protocol adopted to examine the mandible using Micro-CT
In our study all specimens were imaged by micro-CT (inspeXio SMX-90CT; Shimadzu Sci‐
ence East Corporation, Tokyo, Japan)
• After removing only the soft tissue, the mandibular plane is set orthogonal to the sample
stage.
• Three dimensional images of each hemi mandible are acquired with a resolution voxel
size of 15 μm / pixel.
• Raw data are obtained by rotating the sample stage 360 degrees. Then, slice images are
prepared using multi-tomographic image reconstruction software (MultiBP; Imagescript,
Tokyo, Japan).
• The resulting gray-scale images are segmented using a low-pass filter to remove noise
and a fixed threshold to extract the mineralized bone phase.
• The volume of interest (VOI) is drawn on a slice-based method starting from the first slice
containing the crown of the first molar and moving dorsally 100 slices [34, 35], in the area
of the alveolar crest (Between the buccal and lingual roots of the second molar at the cer‐
vical region); and the buccal surface of the jaw bone [29]. Trabecular bone was carefully
contoured on the first and the last slice, while the intermediate slices were first interpolat‐
ed by morphing.
• For observation and analysis of reconstructed 3D images, 3D trabecular structure analysis
software (TRI/3D-BON; RATOC System Engineering, Tokyo, Japan) is used [36]. Recon‐
structed 3D images were prepared from slice images using the volume rendering method,
to analyze the microstructure of the bone (Fig. 16).
• The following parameters are measured: tissue volume (TV), bone volume (BV), bone sur‐
face (BS), bone surface / bone volume (BS/BV), bone-volume fraction (BV/TV).
• Four properties of the trabeculae are evaluated: trabecular thickness (Tb.Th), trabecular
number (Tb.N), trabecular separation (Tb.Sp), and Trabecular space (Tb.S) [36].
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Figure 16. The left mandible was imaged by micro-CT
2.10.7. Microtomography of the DM mandible
The quantification of micro-CT trabecular bone changes (mean±SD) is shown for the DM
and the control groups in (Table 4). All trabecular parameters in both alveolar bone and buc‐
cal surface of jaw bone showed significant changes. Compared with the control group, bone
volume fraction (BV/TV) was significantly decreased only in the alveolar bone; however,
trabecular thickness (Tb.Th) and trabecular numbers (Tb.N) were significantly decreased
both in alveolar and buccal surface of jaw bone, in the DM group. Correspondingly, signifi‐
cantly higher trabecular separation (Tb.Sp) and trabecular space (Tb.S) were revealed both
in alveolar and buccal surface of jaw bone for the DM group when compared with that of
the control group. Also, the bone surface / bone volume (BS/BV) was significantly increased
only in alveolar bone (P< 0. 05). These findings indicate deterioration of the bone quality in
the DM group. These results agree with other research work suggesting that the glycaemic
levels play an important role in modulating the trabecular architecture especially in mandib‐
ular bone [15].
The DM condition resulted in alteration of the trabecular distance and thickness as com‐
pared to the control group indicating profound impact on the histological integrity of the
bone. The reduction in trabecular bone volume accompanied by the expansion of the bone
marrow space is in agreement with another investigation [37]. In this context, these results
may describe a state of osteopenia in experimental diabetic rats, which might be the result of
an imbalance between bone formation and resorption
2.10.8. Procedure for preparing mandibles for histological analysis
• Mandibles for all groups were decalcified in 10% EDTA solution pH 7.4 for 5 weeks at
4ºC [38].
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• Specimens are then dehydrated in an ascending ethanol series and embedded in paraffin
(Fig. 17).
• Serial horizontal sections (5 μm thick parallel to the occlusal plane) are prepared using a
microtome (Leica RM 2155,Nussloch,Germany)(Fig.17)
Figure 17. Experimental procedure for histological section preparation
2.10.9. TRAP staining
Histological sections are incubated for 30–60 min at 37ºC in a mixture of 0.8% naphthol AS-
BI phosphate (Sigma, St Louis, MO, USA), 0.7% fast red violet salt (Sigma, St Louis, MO,
USA) and 50mM sodium tartate diluted in 0.2M sodium acetate buffer (pH 5.4). Sections
were examined under a light microscope. For the histomorphometric assessment of resorp‐
tion, the number of tartrate-resistant acid phosphatase-positive multinucleated cells (osteo‐
clasts) on the distal surface of the alveolar bone adjacent to the mesio-buccal root of the
second molar were counted in each 540 μm x 120 μm area in five consecutive sections, at the
middle third of the root selected at least 25μm apart from each specimen (n = 5) of each
group [39, 40].
2.10.10. Histological analysis
Bone-resorption activity was assessed by counting the number of tartrate-resistant acid
phosphatase-positive multinucleate cells (osteoclasts) on the distal surface of the alveolar
bone adjacent to the mesio-buccal root of the second molar (Fig. 18A-D). Statistical analysis
demonstrated a significantly higher number of osteoclast cells in the control group when
compared with the DM group (P < 0.05) (Fig. 18 E). Results revealed that the number of os‐
teoclasts was significantly lower in the DM rats than in the controls, in line with previous
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studies on DM rats’ mandible [40] and long bones [41, 42]. These results confirm that the de‐
creased rate of bone turnover may be associated with the DM condition.
Figure 18. Osteoclast counts in a horizontal section of the mandibular second molar region stained with Tartarate-
resistant acid phosphatase (TRAP). (A) Low magnification photograph of the three roots of the second molar stained
with TRAP stain. The black rectangle (540 X 120 μm) indicates the area on the distal surface of the alveolar bone adja‐
cent to the middle third of the mesio-buccal root of the second molar in which the osteoclast cells were counted. Bu,
buccal; Li, lingual; Me, mesial; Di, distal. (B) The mesio-buccal root of the control rat (original magnification 100X). (C)
The mesio-buccal root of the DM rat (original magnification 100X). (D) A schematic drawing showing the observation
area on the distal surface of the alveolar bone adjacent to the mesio-buccal root of the second molar in which the
osteoclast cells were counted. (E) Statistical analysis demonstrated a significantly higher number of osteoclast cells in
the control group when compared with the DM group (P < 0.05).
2.11. Suggested mechanisms for the effect of diabetic condition on craniofacial complex
Growth of the craniofacial complex is controlled by genetic and environmental factors [2,
10]. Regulatory mechanisms responsible for normal morphogenesis of the face and head in‐
volve hormones, nutrients, mechanical forces, and various local growth factors. The poor
growth and alterations in bone metabolism have been associated with T1DM in both hu‐
mans and experimental animals [2]. Because human studies can be limited by small sample
sizes, cross-sectional designs, uncontrolled variables, and often retrospective nature, animal
models have been used to yield more rigorous analyses [10]. In our studies we observed the
rat growth from the age of 3 weeks old till 7 weeks old. This time period is corresponding to
early growth stage in human according to previous craniofacial growth studies [43, 44].
Consequently, in the current study STZ-DM model was used to investigate the effect of
T1DM on craniofacial growth.
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The studied STZ-DM rats showed significantly reduced growth in most of the craniofacial
skeletal units but no significant differences were observed between controls and DM group
as regards the remaining craniofacial skeletal units (Sphenoid bone length, posterior neuro‐
cranium height, anterior corpus length, bigonial width and palatal width). Craniofacial
growth as a whole was also significantly lower in DM group compared to controls in all
three dimensions. Previous study investigated the DM effect exclusively on the growth of
the mandible and suggested that the diabetic condition had a differential effect on the oss‐
eous components and / or its associated non-skeletal tissues. They found that the disharmo‐
nious growth of the mandible was due to DM condition and might not be associated with
diabetic condition complications such as renal failure, anemia, body weight change or alter‐
ation in the food intake qualities [2]. Thus we hypothesize that the deficiency in the craniofa‐
cial growth in our experiment might be attributed to the diabetic condition in the DM group
as it was reported that specific alterations in bone metabolism are associated with DM.
Moreover, several pathogenic possibilities have been proposed, such as insulinopenia, bone
microangiopathy, impaired regulation of mineral metabolism, alterations in local factors
that regulate bone remodeling, and even an intrinsic disorder associated with T1DM [37,
45]. The aforementioned insulin hormone deficiency that is associated with T1DM cases may
have direct effect on bone metabolism. It was mentioned in literature that normal insulin
hormone level exerts direct anabolic effects on bone cells [37]. Multiple osteoblast-like cell
lines express insulin receptors on the cell surface and have a high capacity for insulin bind‐
ing [46]. Moreover, osteoclasts exhibit reduced bone resorption in response to insulin stimu‐
lation [47]. These findings support the idea that the actions of insulin in bone could be
mediated directly via stimulation of osteoblasts in combination with inhibition of osteo‐
clasts, [15, 47] and this mechanism of action may explain the retardation of craniofacial
growth in STZ-DM.
Diabetes has a deleterious effect on osseous turnover due to decreased osteoblast and osteo‐
clast activities and numbers and, a lower percentage of osteoid surface and osteocalcin syn‐
thesis, as well as increased time for mineralization of osteoid [37]. It was reported that the
influence of diabetes on discrete stages of matrix-induced endochondral bone formation
could have profound effects on the biomechanical behavior of bone. Also, chondrogenesis
and calcification of bone were reduced by 50% in diabetic animals [48]. This was evident in
the current study results that showed a significant decrease in the craniofacial linear meas‐
urements of the DM group.
In addition to this, insulin may exert synergistic effects with other anabolic agents in bone,
such as parathyroid hormone (PTH) [15, 47]. An animal model of T1DM has frequently
demonstrated alteration in bone turnover, retarded growth, increased concentration of PTH,
and reduced concentration of 1,25-dihydroxivitamin D [37, 49]. The effects of PTH on the
bones are complex; it stimulates resorption or bone formation depending on the concentra‐
tion used, the duration of the exhibition, and the administration method [37, 48, 49, 50]. Al‐
so, 1,25-dihydroxivitamin D, like PTH, belongs to the most important group of bone
regulatory hormones. It regulates osteoclastic differentiation from hematopoietic mononu‐
clear cells, and osteoblastic functions and activity [37, 51].
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Moreover, Insulin may indirectly regulate the enhancement of growth hormone (GH) serum
concentration by direct regulation of the hepatic growth hormone receptor, this results in
abnormalities in the insulin growth factor-1 (IGF-1) in T1DM [52] which consequently may
have lead to the retarded growth in uncontrolled DM in the current study.
In the present study most of the periosteal surfaces in the mandibular regions of the control
group showed significantly higher values recorded for the mineral apposition rate and the
bone formation rate when compared to the DM group. These results agree with previous
studies that recorded diminished lamellar bone formation in DM rats’ femur and may sug‐
gest an association between the DM condition and the decreased number and function of
osteoblasts [16, 19]. The alveolar crest region was the only region that did not show a signifi‐
cant difference in the mineral apposition rate and the bone formation rate parameters
among the two groups; this may be attributed to the unique nature of this region exhibiting
a highly intensive bone remodeling process especially during the teeth eruption that de‐
creases toward the base of the socket [33].
A significant decrease of bone volume fraction, trabecular thickness, and trabecular numbeis
confirmed by Micro-CT analysis in DM rats, there was Also, it showed a significant increase
of the trabecular separation and the trabecular space in the DM group when compared with
the control group. This finding indicates deterioration of the bone quality in the DM group.
These results agree with other research work suggesting that the glycaemic levels play an
important role in modulating the trabecular architecture especially in mandibular bone [15].
In this context, these results may describe a state of osteopenia in experimental diabetic rats,
which might be the result of an imbalance between bone formation and resorption.
A histometric evaluation of bone resorption was performed by counting the number of os‐
teoclast cells on the distal surface of the alveolar bone adjacent to the mesio-buccal root of
the second molar. These evaluations revealed that the number of osteoclasts was significant‐
ly lower in the DM rats than in the controls, in line with previous studies on DM rats’ man‐
dible [40] and long bones [41, 42]. These studies confirm that the decreased rate of bone
turnover may be associated with the DM condition.
This deteriorating effect on mandibular bone structure and dynamic bone formation might
be be attributed to several pathogenic possibilities, such as insulinopenia, bone microangi‐
opathy, impaired regulation of mineral metabolism, alterations in local factors that regu‐
late bone remodeling, and even an intrinsic disorder associated with DM [12, 37]. However,
the detrimental  effects  observed may not  be associated with the significant  loss  of  rats`
weights observed in the diabetic group starting from day 14 because previous research [2,
12, 15, 42] showed that the mandibular growth was not affected in normal rats supplied
with restricted diet and having same pattern of weight loss resembling weight loss pat‐
tern observed in DM rats.
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3. Effect of Type 1 Diabetes on teeth susceptibility to caries
3.1. Tooth formation
Tooth growth begins before birth and continues throughout adolescence. The dental develop‐
ment is a continuous process of tooth initiation, matrix secretion, crown mineralization, den‐
tal eruption, and root completion. Primate dental development begins before birth with initiation
of the deciduous dentition, followed by initiation of the permanent dentition. During the
process of dental eruption the tooth must move past the bone margin (alveolar eruption) and
the gum (gingival eruption) in order to emerge into the oral cavity and eventually into functional
occlusion. Dentine is formed when odontoblasts secrete a collagenous matrix predentine which
rapidly undergoes mineralization to form primary dentine. Dentine formation begins at the
dentine horn underlying the future cusp tip and progresses inward through secretion and
downward through extension until it reaches the apex of the root. Enamel is formed when
ameloblasts secrete enamel matrix proteins that mineralize into long, thin bundles of hydrox‐
yapatite crystallites known as enamel prisms. As the secretory cells progress outward to‐
ward the future tooth surface, additional adjacent cells are activated through extension until
the forming front reaches the cervix of the crown [3].
The resistance of the dental tissues to caries is determined by the quantitative content of the
inorganic and organic matrices. Numerous reports have showed that teeth with a correct
macro- and microstructure and a proper degree of mineralization are more resistant to the
activity of external cariogenic factors [3].
Several biological complications in patients suffering from type 1 diabetes mellitus have
been widely investigated over the previous years, however, the scientific data available on
the possible effects of T1DM on teeth are scant. These data suggest that T1DM condition
may be associated with a change in the chemical composition of the teeth or alteration in the
total thickness of enamel or dentin.
Various clinical studies on children reported high caries prevalence in diabetic children
when compared with healthy controls [3]. This high caries prevalence may be associated
with factors affecting the tooth structure itself or due to some changes in the oral environ‐
ment causing the increase of the susceptibility of the teeth to dental caries.
3.2. Effects of Type 1 Diabetes on tooth mineral composition
Proper mineralization of teeth during its development is the key factor for the proper resist‐
ance of teeth to cariogenic challenge and thus any metabolic disorder affecting the teeth
mineralization during its development may render these teeth more prone to be involved by
caries. Rat experimental model provides an excellent model for the study of the various met‐
abolic disorders on the mineralization of teeth hard tissues due the fact that the rats incisors
are continuously growing and erupting during its life and thus it is possible to study vari‐
ous effects of metabolic disorders which can be induced artificially during the growth peri‐
od of these rats [53]. The results obtained from the aforementioned experimental rat model
can be compared to the results obtained from control rats living under identical situations
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and thus can easily eliminate many variables that can affect the outcome of the results of
any experiments conducted on humans.
In vitro studies on animal models affected by the streptozotocin induced diabetic condition
showed that there is a low concentration of calcium and fluoride in the growing rats` inci‐
sors after inducing the diabetic condition by the streptozotocin injection [54]. Moreover, there
was a concomitant increase in the concentration of calcium in blood serum and a decrease in
fluoride concentration in blood serum. It was suggested that the decrease of calcium concen‐
tration in the teeth structure in this study was due to decrease of the cellular activity of
ameloblasts during the enamel development [54]. This suggestion may be backed by the results
obtained from a similar streptozotocin induced diabetic rat model which showed that the
diabetic condition is associated with a decrease in the calcium deposition in bone due to a
generalized metabolic activity decrease [12, 28]. The recorded increase in calcium in blood
serum was attributed to the absence of insulin which aids in the transfer of calcium from the
blood serum to the body tissues. The low concentration of fluoride observed in the tooth
structure and in the blood serum may be attributed to the incorporation of the fluoride in bone
matrix which is induced by the high concentration of the estrogen observed in the blood serum
[54]. Moreover, the increase in fluoride elimination in urine may have caused this decrease in
fluoride concentration in the diabetic rats.
3.3. Effects of Type 1 Diabetes on salivary status
The saliva contents and rate of flow are among the critical factors that predict the caries inci‐
dence in the oral cavity. Type 1 DM is among the endocrine disease that elevates the glucose
level concentration in saliva and decreases the salivary rate of flow.
The mechanism by which the glucose level may increase in saliva may be explained by previous
research showed that the increase of blood glucose level in T1DM cases is associated with a
concomitant increase of glucose level in saliva. Moreover, it was previously suggested that
T1DM causes an increase in the permeability of the basement membrane of the parotid gland
that favors the transfer of glucose from the parotid gland to the saliva in the oral cavity [3].
The mechanism by which T1DM decreases the salivary flow may be attributed to the detri‐
mental effects induced by the T1DM condition on the salivary gland tissues itself causing a
generalized decrease in the saliva in the oral cavities.
The factors of increased glucose level and decrease in salivary flow cause the improper clearance
of glucose from the oral cavity and impairs the buffering capacity of saliva rendering it more
acidic,  these aforementioned effects  consequently increase the metabolic  activities  of  the
bacterial biofilm in the oral cavity and render teeth more susceptible to dental caries [3].
Previous research work [3] showed that the dietary habits conducted by the diabetic pa‐
tients do not have a significant effect on the prevalence of caries in these patients when com‐
pared to normal individuals and thus it may be concluded that the increase in caries
prevalence in diabetic patients is likely associated with factors affecting the development of
teeth or due to some detrimental effects induced by the oral environment that increases the
risk of caries occurrence in oral cavities of T1DM patients.
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4. Conclusions
It is obvious that the T1DM condition significantly affects craniofacial growth, bone forma‐
tion mechanism and the quality of the bone formed which may alter many aspects of plan‐
ning and treatment of orthodontic patients affected by this globally increasing hormonal
disturbance. Moreover, T1DM condition impairs the proper tooth development and alters
the oral environment rendering teeth more susceptible to dental caries.
There should be a new strategy for treating orthodontic patients suffering from metabolic
disorders specially those disorders having direct and indirect effects on bone growth as the
diabetic condition. The orthodontic craniofacial linear measurements were significantly de‐
creased in the T1DM cases when compared to normal cases. Moreover, greater risks of de‐
veloping dental caries and possible tooth loss are associated with patients suffering from
T1DM; these risks may complicate the outcome of orthodontic treatment which is associated
with less ability of orthodontic patients to implement proper oral hygiene measures due to
increased areas of bacterial biofilm formation around orthodontic brackets
These comprehensive studies done on bone and craniofacial growth suggest that planning
the treatment in craniofacial region for patients affected with hormonal disorders is a more
complex procedure when compared to the treatment of normal patients, moreover it is sug‐
gested that it is of prime importance to keep close attention to the general systemic condi‐
tion of these patients and administer the proper hormonal therapy for these patients when
needed to avoid any detrimental effects on bone resulting from any hormonal imbalance.
Moreover, it is highly recommended to closely monitor the salivary and the dental condi‐
tions of these patients to allow early intervention for treating any developing dental caries.
Within the limitations of this in vitro study, it was concluded that:
1. T1DM reduces craniofacial growth, resulting in retardation of skeletal development.
2. DM in the rat affects the bone architecture, as shown by Micro-CT, and impairs the rate
of the mandibular bone formation, as examined by the dynamic histomorphometric
analysis.
3. All of these results were verified on the cellular level by a histological study that
showed the diminished number of osteoclasts on the alveolar wall, suggesting that the
early stage of DM resulted in low bone turnover.
4. These findings should be considered when conducting any treatment in the craniofacial
region in T1DM since the better understanding of how diabetes affects bone will im‐
prove our ability to protect bone health in diabetic patients.
5. The tooth structure and the saliva condition are negatively influenced by the T1DM
condition and thus strict oral hygiene measures should be conducted with orthodontic
patients suffering from T1DM condition to decrease the risk of developing dental caries
in these patients.
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6. Good control of diabetes mellitus should be considered before orthodontic treatment by
a long time inorder to obtain the best outcome.
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